Bumetanide, an FDA-approved diuretic drug, improved the symptoms of children diagnosed with autism, reducing their average autism scores from severe to mild or moderate, French researchers found. "Bumetanide is an interesting and promising medication," says Dr. Andrew Adesman of Cohen Children's Medical Center in New Hyde Park, N.Y., who was not involved in the study. Although the medication is on the market and appears to be safe, he urged doctors and families to wait for more research before using it. The findings, based on 60 3- to 11-year-olds with autism, appear in the journal Translational Psychiatry.
Published in Brief: